Geodesic Sensor Net (HCGSN) may be useful. HCGSN does not require any scalp preparation or abrasion and is suitable for all patient ages. Application times for the spongebased HCGSN range between 5 minutes for 32 channels to 15 minutes for 256 channels. A digital video system is crucial, as is warranty and support. Equally important are on-site installation and training visit by a support engineer providing reference materials and manuals. Regular training workshops of the staff are usually required and helpful.
A reviev of some commercially available Monitoring Systems is given in Table 1 .
AirEEG WEE-1000 Nihon Kohden Corporation
The patient wears a transmitter in a pouch and an electrode junction box in a shoulder strap. The transmitter sends up to 64 channels of EEG data to one or more receivers that are connected to an electroencephalograph by LAN. Wireless is more comfortable.
Beehive® 
Diagnostic yield of LTM in the differential diagnosis between epilepsy and paroxysmally occurring nonepileptic conditions
Events that may cause diagnostic confusion with epilepsy are (a) Non-epileptic pathophysiological events, such as autonomic disorders, cardiac arrhythmias, drug toxicity, metabolic disorders, migraine, orthostatic hypotension, sleep disorders, valvular heart disease, vasovagal syncope, vestibular disorder, and (b) Non-epileptic psychopathological and psychiatric events, such as anxiety, depression, panic attacks, psychogenic "seizures" and other somatoform disorders, and psychosis.
Approximately 20% of patients referred to comprehensive epilepsy programs because of medically "refractory" seizures do not have epilepsy. In the study of Benbadis et al [1] , 75 patients (30%) of 251 patients with video EEG monitoring had non-epileptic attacks: 69 without epilepsy and 6 patients combined with epileptic attacks. 61 patients from the 69 patients had so-called "psychogenic" and 8 patients had "other" attacks.
Yogarajah et al. [2]
studied the value of the ILAE-recommended use of LTM. All admissions to the Sir William Gowers Unit at the National Society for Epilepsy (an epilepsy tertiary referral unit) in the years 2004 and 2005 were included. In this study LTM was primarily responsible for a change in the diagnosis in 133 (58%) and a refinement of diagnosis in 29 (13%) patients. The most common change was in distinguishing epilepsy from non-epileptic attack disorder (NEAD) in 73 (55%) and in distinguishing between focal and generalized epilepsy in 47 (35%). LTM was particularly helpful in differentiating frontal lobe seizures from generalized seizures and non-epileptic attacks.
Besides the diagnosis of a seizure disorder and the classification of seizure types, the evaluation of precipitating factors and the quantification of seizures is often very important. Surgical localization is another issue and briefly dealt below.
LTM in the context of presurgical evaluation of candidates for epilepsy surgery
LTM in specialized institutions offering epilepsy surgery is often divided into a Phase 1 and Phase 2. Phase 1 is noninvasive. In this early stage of examination, three main questions have to be answered: (1) Is it epilepsy? (2) What type of epilepsy? And (3) Is it pharmacotherapy resistant? Phase 2 consists of semi-invasive, and invasive techniques to pinpoint the area(s) where the seizures originate if pharmacotherapy-resistant epilepsy has been determined. Only when a surgically remediable seizure onset zone is determined,then curative epilepsy surgery can be considered.
Epilepsy surgery includes the categories curative (=causal =resective) and palliative epilepsy surgery. Curative means resection of the primary epileptogenic zone, i.e. resection of the actual and potential seizure onset zone. The goal is postoperative seizure freedom. Types of resections include more or less standardized resections as opposed to tailored resections. Standardized resections include interventions such as the "selective amygdalohippocampectomy" [3-4], anterior temporal lobe resection, and functional hemispherectomy (see Figure 1 ).
Not infrequently the localization of the seizure onset zone in so-called "eloquent", i.e. indispensable brain area and/or the size of the seizure onset zone prevent its radical therapeutic excision. In such a case the "secondary pacemaker areas" (e.g. "ipsilateral discharge amplifiers") may be targeted. For example, in a left posterior neocortical temporal lobe epilepsies with rapid propagation of the discharge into the ipsilateral mesial temporal structures (-which act then as a secondary pacemaker -) a so-called "palliative hippocampectomy" has sometimes been performed with good results [5] . However, palliative interventions usually cannot provide postoperative seizure freedom, but may Illustration of the conceptual zones of the "epileptic" focus. The lesional zone is characterized by the anatomical, i.e. morphological lesion; the irritative zone by the territory exhibiting "interictal spiking". The functional deficit zone is characterized by neurological and/or neuropsychological deficits and/or functional imaging (PET,SPECT) abnormalities; the symptomatogenic zone, by the "primictal", i.e. very early, ictal signs and symptoms. Depending whether the patient is rendered seizure-free or not after surgical excision, the seizure onset zone can be further divided into an actual and potential seizure onset zone.
ameliorate the patient`s seizure situation. Palliative procedures include callosal section (i.e., corpus callosum section, CCS; including Gamma Knife CCT), vagal nerve stimulation (VNS) and deep brain stimulation (DBS).
Curative epilepsy surgery relies on the concept of the "epileptic focus". At least for practical purposes, the "focus"-concept is still valuable, although the network hypothesis might be more realistic. Using stereo-electroencephalography (SEEG) Talairach and Bancaud have described a "zone lésionelle", a "zone irritative", and a "zone épileptogène" [6]. Wieser [7-8] and Lüders [9] enlarged the focus concept to the following zones (1) lesional (2) primary epileptogenic, (3) secondary epileptogenic (including the "mirror focus", and the "ipsilateral discharge amplifier"), (4) irritative, (5) functional deficit, and (6) symptomatogenic. Lüders et al.
[10] then divided the epileptogenic zone into the (a) actual, and (b) potential seizure onset zones, depending whether the patient is rendered seizure-free or not after surgical excision. It is very important to note that the seizure onset zone is not identical with the lesion. Often it is in the vicinity of a lesion, but can be located in or involve remote areas [ Figure 2 ].
Long-term video-EEG monitoring can be performed using conventional scalp electrodes, "true temporal electrodes", sphenoidal electrodes, and in the context of presurgical evaluation the so-called semi-invasive and invasive techniques. The positioning of the 7 depth electrodes (indicated by large and bold numbers) is indicated in the brain map. Each depth electrode has 10 contacts numbered 1 to 10 from inside to outside (small numbers). At the right ambulatory SEEG monitoring is illustrated (University Hospital Zurich 1984).
of spike activation and seizure precipitation associated with different sleep stages ( Figure  8 ) and seizure prediction (Figure 9 ). For the latter the pre-ictal spike frequency, the surface negative DC-shift, the inter-and intrahemispheric coupling strength , and some indicators derived from the "chaos theory" (e.g. Lyapunov-exponents and correlation dimension) have been examined. Figure 9 is an example that nonlinear time-series analysis with neuronal complexity loss in interictal EEG recorded with foramen ovale electrodes can predict a seizure. However, in the illustrated case the calculation was done off-line [15-16]. Bottom left: Graphical display of compressed spectral array over 3 hours (05.00 to 08.00 a.m) showing 4 seizure dicharges in the depth EEG recording from right amygdala. The arrow indicates the spectral edge frequency (SEF) marker set at 97%. Measurement time is 120 msec, power range is -20 to -60d. Frequency is from 0 to 32 Hz. Bottom right: Example of the summary display of a surface EEG-LTM (18:05 to 09:45) using the automatic seizure detection Grass-Telefactor TWin 2.60 software. The patient had numerous subclinical seizure discharges (indicated by green bars) and one clinical seizure (indicated by the yellow bar; the circle denotes alarm button press). Quantification of seizure discharges during the black vertical bars revealed more than 20 discharges/hour. 
LTM in the diagnosis and treatment of status epilepticus
Continuous EEG (cEEG ) monitoring of critically ill patients is frequently utilized to detect non-convulsive seizures (NCS) and non-convulsive status epilepticus (NCSE). Abend et al.
[17] studied the current practice of cEEG in critically ill patients. The authors conducted an international survey of neurologists focused on cEEG utilization and NCS management: 83% of 330 physicians who completed the survey used cEEG at least once per month and 86% managed NCS at least five times per year. The use of cEEG in patients with altered mental status was common (69%), with higher use if the patient had a prior convulsion (89%) or abnormal eye movements (85%). Most respondents would continue cEEG for 24 h.
If NCS or NCSE was identified, the most common anticonvulsants administered were phenytoin/fosphenytoin, lorazepam, or levetiracetam, with slightly more use of levetiracetam for NCS than NCSE.
Continuous EEG monitoring in the Intensive Care Unit
In the ICUs, cEEG monitoring reveals the presence of electrographic seizures in a significant percentage of critically ill patients and in patients with depressed levels of consciousness [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . cEEG monitoring is primarily conducted to detect epileptic seizures. It helps assessing the long-term EEG trends and the level of sedation; both essential for treatment and prognosis. Another argument to perform cEEG monitoring in the ICU is costcontainment: In a retrospective study of refractory status epilepticus (RSE) following NCSE (RSE defined as seizures lasting more than 60 minutes and failure of two AEDs), Mayer et al. [30] concluded that it is imperative to diagnose and treat NCS/NCSE as early as possible since the prognosis worsens with increasing duration of seizures which will prolong these patients stay in the ICU and consequently increase the cost on health care ressources.
ICU patients that should undergo cEEG monitoring
NCSE is usually diagnosed when facing a patient with an abnormal mental status and diminished responsiveness, a "compatible" EEG, and frequently a clinical response to antiepileptic therapy. Kaplan [27] asks for both, an alteration in the level of consciousness for 30 to 60 minutes and some seizure activity in the EEG to diagnose NCSE. The EEG remains the most important tool to diagnose NCSE. NCSE can be found in different patient populations, for example in psychiatric and mentally retarded patients on psychotropic medications, and in patients with a history of epilepsy after a tonic-clonic seizure. NCSE/NCSs are common in critically ill patients [19, 21] . Therefore, we believe that ICU patients with impaired consciousness, especially those patients with unclear etiology, should undergo cEEG monitoring. Clinical conditions where it is appropriate to look for NCSE, are: (a) unexplained diminished level of consciousness (with or without limb and facial twitching and/or eye deviation) in the ICU; (b) confusional states or altered mental status in patients in the emergency room [31]; (c) patients with persisting lethargy or behavioral changes after a tonic-clonic seizure [32], (d) psychomotor retardation or behavioral changes beyong baseline in a psychiatric or mentally retarded patient;

Lethargy and confusion attributed to a postictal state  Ictal confusion mistaken for metabolic encephalopathy  Unresponsiveness and catalepsy presumed to be psychogenic  Obtundation thought to be due to alcohol or drug intoxication  Hallucinations and agitation mistaken for psychosis or delirium  Lethargy presumed secondary to hypoglycemia  Mutism attributed to aphasia  Laughing and crying ascribed to emotional lability Table 2 lists clinical examples in which the diagnosis of NCSE was missed or delayed.
Epidemiology of NCSE
There have been no large-scale population-based studies regarding selectively NCSE. Dunnes et al. [37] estimate that NCSE constitutes 20% of all status epilepticus in adults.
Recent populations-based studies have reported a higher percentage of NCSE among all status epilepticus (30% to 60%) [38] [39] [40] [41] [42] . This wide range is explained by the difference in NCSE definition, classification and probably the differences in population characteristics. Knake et al. [40] reported the highest proportion of NCSE in the adult population. Both the large number of patients over 65 years, and the history of stroke and epilepsy might explain this unusually elevated percentage of NCSE in this study. Shorvon [43] reports an annual incidence of NCSE ranging from 5 to 11 per 100,000. Shorvon`s figures are likely underestimates because of the challenges in diagnosing NCSE and also the need for continuous EEG monitoring. 
Duration of monitoring in the ICU

Pathological EEG patterns commonly occurring in the critically ill patient
A large spectrum of ictal EEG abnormalities may be seen in the ICU, particularly with NCSE [45-46]: Periodic short-interval diffuse discharges (PSIDD) are usually seen in anoxia, metabolic encephalopathy, Creutzfeldt Jakob disease, and toxic encephalopathy (lithium and baclofen). Periodic long-interval diffuse discharges (PLIDD), also called Radermecker complexes, are seen in patients suffering from Subacute Sclerosing Panencephalitis (SSPE) and in patients with Phencyclidine ("angel dust") or ketamine intoxication [47-51]. PLIDDlike patterns are also seen in anoxia and barbiturate intoxication.
The following benign electroencephalographic variants and patterns of uncertain significance may appear during cEEG monitoring but have to be separated from the EEG findings described above Moderate to high voltage monorhythmic and sinusoidal 1rhythmic delta 3 Hz activity seen bilaterally maximal in anterior leads, no evolution Table 3 . Definitions of EEG patterns in ICU seizures given by Claassen [19] www.intechopen.com Epilepsy -Histological, Electroencephalographic and Psychological Aspects 158
Controversial EEG patterns
NCSE is accompanied with EEG patterns that are often seen with clinical seizures; however many EEG patterns are called "controversial", because the question whether they are ictal in nature or not, is still debated.
Periodic patterns
These include periodic epileptiform discharges (PEDs) which can be generalized (GPEDs) or lateralized (periodic lateralized epileptiform discharges, PLEDs); or bilateral independent periodic epileptiform discharges (BIPLEDs). these patterns should be considered as ictal when they evolve from lower to faster rates(>2 Hz), change their frequencies, morphology or field (PLEDs-plus). PLEDs are shown in Figure 10 .
BIPLEDs are less common than PLEDs; the complexes are asynchronous; their morphology, amplitude, frequency and location generally differ from one hemisphere to the other. They Figure 11 .
GPEDs [ Figure 12 ] occur in anoxic-ischemic coma, Creutzfeld-Jacob disease, metabolic encephalopathies, CNS infections such as SSPE , H S V , a n d i n f i n a l s t a g e s o f s t a t u s epilepticus. GPEDs may represent NCSE [63] or an epileptic encephalopathy [64-65]. Fig. 11 . This EEG shows bilateral independent peudoperiodic lateralized epileptiform discharges in an obtunded patient with left hemisphere complexes every several seconds, independent from right-sided discharges.
Triphasic waves (TWs)
In NCSE/NCSs, Kaplan [66] describes the TWs as follows: Surface-negative, blunted triphasic complexes with (a) low amplitude, blunted, negative first phase (often widebased); (b) dominant, steep positive second phase, and (c) slow rising third slow-wave component. No polyspike component. Complex duration: 400-600 msec; amplitude: 100 to 300 uV on referential montage; smaller on bipolar. Frequency: 1.0-2.5 Hz (typically 1.8 Hz); persistence: wax and wane, but more than 10% of a standard recording (20 min). Evolution/reactivity: decrease in sleep, drowsiness or after BZPs; increase and reappear with arousal or noxious stimulation. May exhibit phase-lag best seen on referential montage. TWs may present an epileptiform morphology with spike-like ongoing first phases, and spike-slow-wave complexes. In such cases, it is not easy to differentiate NCSE from metabolic encephalopathy, particularly when TWs run at a frequency exceeding 1 per second. Hence there exist the terms triphasic-like waves and nonepileptic true TWs [63]. Indeed, in NCSE, TWS and generalized spike-wave discharges look similar. In metabolic encephalopathies, in Creutzfeld-Jacob disease, and in the course of status epilepticus, bisynchronous periodic sharp complexes with a triphasic configuration are frequently found [58,67-69] . The generalized periodic patterns, associated with lithium, baclofen, ifosfamide, metrizamide, tiagabine, and levodopa, might represent NCSE [70 -75] . TWs are also reported in Alzheimer disease [76] . TWs are shown in Figure 13 and " Epileptiform triphasic waves" in Figure 14 . SIRPIDs. Stimuli-induced rhythmic periodic, or ictal discharges [SIRPIDs] were first described by Hirsch et al [77] . These are periodic discharges, focal or generalized, frequently seen immediately after stimulation or arousal of a comatose or stuporous patient. SIRPIDs occur with acute brain disorders (brain injury) and severe metabolic disorders. Is not clear whether SIRPIDs represent reflex seizures, abnormal arousal patterns, or a combination of both. It has been speculated that faster discharges (more than 3Hz) may be ictal, whereas the slower ones are less likely to be ictal. Few patients have clinical correlates to their SIRPIDs. SIRPIDs are shown in Figure 15 .
Nonconvulsive status epilepticus in the critically ill ICU patient
There exists a large literature dealing with classification and electroclinical accompaniments of nonconvulsive status epilepticus (NCSE). NCSE is a heterogenous condition. Its diagnosis is difficult on the basis of clinical semiology alone. An impaired mental status, a reduced responsiveness, a supportive EEG and a response to antiepileptic medications are important criteria to diagnose NCSE. A continuous EEG ictal activity and impaired consciousness for one hour are necessary according to Tomson Of particular interest is the distinction between NCSE (as described above) and an epileptic encephalopathy [80] . In this later condition, the impaired level of consciousness is related to the underlying brain pathology causing the seizures rather than the seizures themselves [22,79,81-83].
Although nonconvulsive seizures and NCSE are common in the critically ill patient, many neurologists may be challenged by the frequent "absence" of specific clinical signs, and the difficulty in interpreting the EEG when confronted to such patients. A trial of rapid acting benzodiazepine might be helpful.
Not infrequently NCSE follows a convulsive status epilepticus [32] . In the study of DeLorenzo et al [32] , using cEEG recording after the control of convulsive status epilepticus, in 164 patients, the authors found that 48% showed persistent electrographic seizures, with NCSE in 14% of them. The authors concluded that the use of cEEG monitoring in these patients was essential in detecting NCSE. Figure 16 shows an example of NCSE. As mentioned above, NCSE following generalized convulsive status epilepticus is often a refractory status epilepticus and carries a high mortality [32] . Therefore, it is imperative to diagnose and treat patients with this condition as early as possible because the prognosis worsens with increasing duration of seizure activity, inducing then more complications and ending with high morbidity and mortality. Fig. 16 . Nonconvulsive status epilepticus (NCSE) evolving from left-hemisphere periodic lateralized epileptiform discharges (PLEDs) in a 66-year-old man with a left frontal intracerebral hemorrhage. Initially the EEG shows periodic discharges at 1,5 per second, which are invariant for several minutes, then gradually increase in frequency and merge to electrographic theta activity over the entire left hemisphere.This pattern repeated every 5 to 10 minutes for several hours.
There is a strong evidence that the marker of neuronal injury, neuron-specific enolase (NSE) is elevated during NCSE [89-91]. In these studies the level of NSE correlated with the duration of SE favorizing an early treatment of NCSE.
Autopsies of patients with NCSE have shown focal neuronal loss. Three patients, who died 11 to 27 days after the onset of focal motor status epilepticus, but without pre-existing epilepsy, showed neuronal loss and gliosis in the hippocampus, amygdala and periamygdalar area, dorsomedial thalamus, Purkinje cells, pirifrom and entorhinal cortices In humans, the underlying pathophysiology of the various subtypes of NCSE has not been investigated in detail [97-98]. The correlation with underlying pathology, EEG patterns, type of treatment and prognosis remains to be studied. Valid data regarding which EEG patterns cause ongoing neuronal damage are still lacking. Therefore we do not know which patient suffering from NCSE should be treated aggressively. Subtle cases of NCSE may resolve spontaneously. Patients with NCSE with minimal obtundation have a morbidity and mortality of 7%, whereas those with deep lethargy or coma have a mortality rate of 39%. [86] . Whereas Treiman [99] explicitly recommends that a patient actively having seizures or being comatose and who exhibits any of the periodic epileptiform discharge patterns on EEG should be treated aggressively to stop all clinical and electrical seizure activity to prevent further neurological morbidity and mortality, Kaplan [100] believes that aggressive ICU management of NCSE in the elderly critically ill patient may be harmful rather than beneficial .
Future study: To develop a novel cEEG monitoring system able to monitor seizures in real time, and adequately treat these seizures in a timely fashion
Available seizure-detection software algorithms are geared towards patients with normal EEG backgrounds and high-frequency rhythmic seizure discharges. Unfortunately these computer algorithms are not very successful to detect NCSs/NCSE in ICU patients. This because (a) these kind of seizures have a tendency to wax and wane and do evolve more slowly when compared to the fast activity seen in convulsive seizures, and (b) these seizures are harder to separate from the abnormal background activity related to the impaired vigilance and the associated metabolic disturbances often found in ICU patients [45] .
In an ongoing study (Mesraoua et al; see also [101]) we are planning to develop a novel cEEG monitoring system to be used in the ICU. This system should be able to detect pathological EEG patterns commonly occurring in the critically ill patient (NCSE and PEDs, TWs). This system should also be able to quantify the frequency and duration of seizures and will make possible an adequate antiepileptic drug (AED) treatment, in a timely fashion, using the recommended antiepileptic drugs in nonconvulsive seizures/NCSE [102-108]. Using the available neuroradiologic tools (MRIs, MRS) and the CNS biomarkers (Neuronspecific Enolase , NSE), we will examine the possibility that brain damage is occuring with NCSE or PEDs. This way we hope to answer the most important question, i.e., whether NCSE and PEDs should be treated aggressively. This study is a combined effort between neuroscientists/neurologists and signal processing specialists in order to develop a software for the cEEG. The technique will use wavelet transforms (WTs) and wavelet packet energy ratio (WPER) which have been proven to be successful tools for epileptic seizure detection, particularly in temporal lobe epilepsy [109-100]. The proposed seizure detection algorithm will perform the following:
1. Subdivide the EEG signal into segments for individual interpretation, 2. Extract features which characterize the individual segments based on EEG behavior in the ICU,
